Patent ID: 11891413
Assignee: IDORSIA PHARMACEUTICALS LTD
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 9:
10. A conjugate comprising an oligosaccharide according to claim 1 covalently linked to an immunogenic carrier through the residue E of the —O-L-E group, wherein the immunogenic carrier is a carrier protein selected from the group consisting of: a diphtheria toxoid, a mutated diphtheria toxoid, a modified diphtheria toxoid, a mutated and modified diphtheria toxoid, a tetanus toxoid, a modified tetanus toxoid, a mutated tetanus toxoid, non-lipidated cell-surface liporotein (protein D) of non-typeable Haemophilus influenzae, outer membrane protein (OMP) complex of Neisseria meningitidis, bovine serum albumin (BSA), keyhole limpet hemocyanine (KLH), recombinant non-toxic form of Pseudomonas aeruginosa exotoxin A (rEPA) or cholera toxoid (CT).